Consensus interferon in combination with ribavirin for hepatitis C patients with nonresponse or relapse to interferon alpha and ribavirin.

被引：0
|
作者：
Buggisch, P
Hinrichsen, H
Hueppe, D
Reiser, M
Kueppers, H
Wursthorn, K
Sterneck, M
机构：
[1] Univ Connecticut, Ctr Hlth, Farmington, CT USA
[2] Waterbury Hosp & Hlth Ctr, Waterbury, CT USA
[3] Manchester Hosp, Manchester, CT USA
[4] Hartford Hosp, Hartford, CT 06115 USA
[5] Yale Univ, New Haven, CT USA
[6] Genesee Hosp, Rochester, NY 14607 USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1672
引用
收藏
页码：590A / 590A
页数：1
相关论文
共 50 条
  • [1] Successful retreatment of chronic hepatitis C patients with a nonresponse to standard interferon/ribavirin using daily consensus interferon and ribavirin.
    Kaiser, S
    Hass, H
    Gregor, M
    HEPATOLOGY, 2004, 40 (04) : 240A - 240A
  • [2] Combination treatment with consensus-interferon and ribavirin for chronic hepatitis C patients with non-response relapse to previous treatment with alpha-interferon and ribavirin.
    Buggisch, P
    Seegers, B
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    de Heer, G
    Wursthorn, K
    Sterneck, M
    HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [3] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Yee, Helen S.
    Currie, Sue L.
    Tortorice, Kathryn
    Cozen, Myrna
    Shen, Hui
    Chapman, Summer
    Cunningham, Fran
    Monto, Alexander
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2439 - 2448
  • [4] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Helen S. Yee
    Sue L. Currie
    Kathryn Tortorice
    Myrna Cozen
    Hui Shen
    Summer Chapman
    Fran Cunningham
    Alexander Monto
    Digestive Diseases and Sciences, 2011, 56 : 2439 - 2448
  • [5] Thyroid abnormalities in patients with chronic hepatitis C treated with interferon-alpha and ribavirin.
    Johnson, A
    Abrams, GA
    Fallon, MB
    Langner, RG
    van Leeuwen, DJ
    McGuire, BM
    Bloomer, JR
    HEPATOLOGY, 2000, 32 (04) : 558A - 558A
  • [6] High viral response rates in previous interferon/ribavirin nonresponder patients with chronic hepatitis C retreated with consensus interferon induction therapy and ribavirin.
    Kaiser, S
    Hass, H
    Gregor, M
    HEPATOLOGY, 2002, 36 (04) : 358A - 358A
  • [7] RESPONSE OF HEPATITIS C PATIENTS TO ALPHA INTERFERON AND RIBAVIRIN COMBINATION THERAPY
    Mahsud, Ihsanullah
    Khan, Rahman-ud Din
    Khan, Muslim
    Hameed, Khalid
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2008, 6 (02): : 65 - 68
  • [8] Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
    Cornberg M.
    Wedemeyer H.
    Manns M.P.
    Current Gastroenterology Reports, 2002, 4 (1) : 23 - 30
  • [9] HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin
    Carlsson, T
    Lindahl, K
    Schvarcz, R
    Wejstal, R
    Uhnoo, I
    Shev, S
    Reichard, O
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (06) : 409 - 413
  • [10] Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C
    Davis, GL
    SEMINARS IN LIVER DISEASE, 1999, 19 : 49 - 55
12345